Trump criticizes FDA's 'slow and burdensome' drug approval process

Views 3.4K

President Trump pledged to "slash the restraints" that are placed on Food and Drug Administration's regulatory process during his speech to Congress. Trump labeled the approval process as "slow and burdensome," preventing lifesaving medicines from reaching those in need of them. Trump told the story Megan Crowley, who experts predicted wouldn't live past 5, but is currently a healthy university sophomore after taking the right medicine. “If we slash the restraints, not just at the FDA but across our government, then we will be blessed with far more miracles like Megan. In fact, our children will grow up in a nation of miracles,” Trump said.

Share This Video


Download

  
Report form